A study on gastric cancer showed that overexpression of METTL1 promoted CTLA-4 and PD-1 expression, suggesting that METTL1 may facilitate immune evasion by enhancing the expression of these inhibitory checkpoints (43). This evidence concerns the gene METTL1 and gastric cancer.